{"title":"用免疫抑制剂和类固醇治疗皮肌炎的卡波西肉瘤一例","authors":"Bandana Bhardwaj, Shivani Thakur","doi":"10.26440/ihrj/0512.03513","DOIUrl":null,"url":null,"abstract":"The incidence of Kaposi's sarcoma has increased in recent years mainly because its association with the acquired immunodeficiency syndrome and organ transplant recipients treated with immunosuppressive drugs, especially with cyclosporine. We present the case of a patient with dermatomyositis who developed Kaposi's sarcoma after receiving treatment with steroids, cyclosporine, and human polyclonal immunoglobulin.","PeriodicalId":306248,"journal":{"name":"International Healthcare Research Journal","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Kaposi's Sarcoma in A Subject Treated for Dermatomyositis With Immunosuppressant and Steroid\",\"authors\":\"Bandana Bhardwaj, Shivani Thakur\",\"doi\":\"10.26440/ihrj/0512.03513\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The incidence of Kaposi's sarcoma has increased in recent years mainly because its association with the acquired immunodeficiency syndrome and organ transplant recipients treated with immunosuppressive drugs, especially with cyclosporine. We present the case of a patient with dermatomyositis who developed Kaposi's sarcoma after receiving treatment with steroids, cyclosporine, and human polyclonal immunoglobulin.\",\"PeriodicalId\":306248,\"journal\":{\"name\":\"International Healthcare Research Journal\",\"volume\":\"4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Healthcare Research Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26440/ihrj/0512.03513\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Healthcare Research Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26440/ihrj/0512.03513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Kaposi's Sarcoma in A Subject Treated for Dermatomyositis With Immunosuppressant and Steroid
The incidence of Kaposi's sarcoma has increased in recent years mainly because its association with the acquired immunodeficiency syndrome and organ transplant recipients treated with immunosuppressive drugs, especially with cyclosporine. We present the case of a patient with dermatomyositis who developed Kaposi's sarcoma after receiving treatment with steroids, cyclosporine, and human polyclonal immunoglobulin.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
